17 beta-estradiol and tamoxifen upregulate estrogen receptor beta expression and control podocyte signaling pathways in a model of type 2 diabetes. [electronic resource]
Producer: 20090826Description: 1194-1201 p. digitalISSN:- 1523-1755
- Animals
- Cell Line
- Diabetes Mellitus, Type 2 -- metabolism
- Diabetic Nephropathies -- drug therapy
- Estradiol -- pharmacology
- Estrogen Receptor beta -- biosynthesis
- Mice
- Mice, Inbred Strains
- Podocytes -- cytology
- Protective Agents
- Signal Transduction -- drug effects
- Tamoxifen -- pharmacology
- Up-Regulation -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.